Qi Liu, Jianhui Yang, Yumeng Xing, Yu Zhao, Yang Liu
{"title":"CRISPR-Cas9基因组编辑递送策略的开发","authors":"Qi Liu, Jianhui Yang, Yumeng Xing, Yu Zhao, Yang Liu","doi":"10.1002/bmm2.12025","DOIUrl":null,"url":null,"abstract":"<p>The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-related protein 9 (Cas9) genome editing system has attracted much attention due to its powerful genome editing capacity. However, CRISPR-Cas9 components are easily degraded by acids, enzymes, and other substances in the body fluids after entering the organism, thus efficiently delivering the CRISPR-Cas9 system into targeted organs or cells has been a central theme for promoting the application of CRISPR-Cas9 technology. Although several physical methods and viral vectors have been developed for CRISPR-Cas9 delivery, their clinical application still suffers from disadvantages, such as the risks of mutagenesis, cell damage, and poor specificity. As an alternative, non-viral nanocarriers hold great promise for circumventing these challenges. Furthermore, with aim to realize more efficient and precise genome editing and reduce the undesirable side effects, stimuli-responsive nanocarriers are designed for the spatiotemporal CRISPR-Cas9 delivery in responsive to various stimuli. In this review, we will summarize the recent progress in delivery strategies for CRISPR-Cas9 genome editing. The mechanisms and advantages of these strategies were reviewed, providing a comprehensive review of the rational design of materials and techniques for efficient and precise genome editing. At last, the potential challenges of current CRISPR-Cas9 delivery are discussed.</p>","PeriodicalId":100191,"journal":{"name":"BMEMat","volume":"1 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bmm2.12025","citationCount":"2","resultStr":"{\"title\":\"Development of delivery strategies for CRISPR-Cas9 genome editing\",\"authors\":\"Qi Liu, Jianhui Yang, Yumeng Xing, Yu Zhao, Yang Liu\",\"doi\":\"10.1002/bmm2.12025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-related protein 9 (Cas9) genome editing system has attracted much attention due to its powerful genome editing capacity. However, CRISPR-Cas9 components are easily degraded by acids, enzymes, and other substances in the body fluids after entering the organism, thus efficiently delivering the CRISPR-Cas9 system into targeted organs or cells has been a central theme for promoting the application of CRISPR-Cas9 technology. Although several physical methods and viral vectors have been developed for CRISPR-Cas9 delivery, their clinical application still suffers from disadvantages, such as the risks of mutagenesis, cell damage, and poor specificity. As an alternative, non-viral nanocarriers hold great promise for circumventing these challenges. Furthermore, with aim to realize more efficient and precise genome editing and reduce the undesirable side effects, stimuli-responsive nanocarriers are designed for the spatiotemporal CRISPR-Cas9 delivery in responsive to various stimuli. In this review, we will summarize the recent progress in delivery strategies for CRISPR-Cas9 genome editing. The mechanisms and advantages of these strategies were reviewed, providing a comprehensive review of the rational design of materials and techniques for efficient and precise genome editing. At last, the potential challenges of current CRISPR-Cas9 delivery are discussed.</p>\",\"PeriodicalId\":100191,\"journal\":{\"name\":\"BMEMat\",\"volume\":\"1 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bmm2.12025\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMEMat\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/bmm2.12025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMEMat","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bmm2.12025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Development of delivery strategies for CRISPR-Cas9 genome editing
The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-related protein 9 (Cas9) genome editing system has attracted much attention due to its powerful genome editing capacity. However, CRISPR-Cas9 components are easily degraded by acids, enzymes, and other substances in the body fluids after entering the organism, thus efficiently delivering the CRISPR-Cas9 system into targeted organs or cells has been a central theme for promoting the application of CRISPR-Cas9 technology. Although several physical methods and viral vectors have been developed for CRISPR-Cas9 delivery, their clinical application still suffers from disadvantages, such as the risks of mutagenesis, cell damage, and poor specificity. As an alternative, non-viral nanocarriers hold great promise for circumventing these challenges. Furthermore, with aim to realize more efficient and precise genome editing and reduce the undesirable side effects, stimuli-responsive nanocarriers are designed for the spatiotemporal CRISPR-Cas9 delivery in responsive to various stimuli. In this review, we will summarize the recent progress in delivery strategies for CRISPR-Cas9 genome editing. The mechanisms and advantages of these strategies were reviewed, providing a comprehensive review of the rational design of materials and techniques for efficient and precise genome editing. At last, the potential challenges of current CRISPR-Cas9 delivery are discussed.